Biorelevant dissolution instruments represent an important tool for pharmaceutical research and development. These instruments are designed to simulate the dissolution of drug formulations in conditions most closely mimicking the gastrointestinal tract. In this work, we focused on the optimization of dissolution compartments/vessels for an updated version of the biorelevant dissolution apparatus—Golem v2. We designed eight compartments of uniform size but different inner geometry. The dissolution performance of the compartments was tested using immediate release caffeine tablets and evaluated by standard statistical methods and principal component analysis. Based on two phases of dissolution testing (using 250 and 100 mL of dissolution medi...
One of the challenges of biopharmaceutics research is correlating in vitro drug release information ...
The general aim of this thesis was to evaluate a newly designed and constructed miniaturized rotatin...
AbstractThe release rate of an active pharmaceutical ingredient (API) from a dosage form, measured b...
Biorelevant dissolution instruments represent an important tool for pharmaceutical research and deve...
Dissolution tests are used for many purposes in the pharmaceutical industry: in the development of n...
Many drugs are administered as crystalline particles compressed into tablets and taken orally. When ...
Dissolution testing with biorelevant media has become widespread in the pharmaceutical industry as a...
The rate and extent of drug dissolution in the gastrointestinal (GI) tract are highly dependent upon...
When dissolution testing is used to forecast the in vivoperformance of a drug, it is critical that t...
In the development of new oral drug compounds, poorly water-soluble compounds are a challenge for th...
Purpose . The dissolution behavior of two commercially availableglibenclamide formulations was teste...
Dissolution research started more than a century ago in the field of physical chemistry and went thr...
Oral drug products must dissolve in the gastrointestinal (GI) tract before being absorbed and reachi...
Over the past decade, formulation predictive dissolution (fPD) testing has gained increasing attenti...
Over the past decade, formulation predictive dissolution (fPD) testing has gained increasing attenti...
One of the challenges of biopharmaceutics research is correlating in vitro drug release information ...
The general aim of this thesis was to evaluate a newly designed and constructed miniaturized rotatin...
AbstractThe release rate of an active pharmaceutical ingredient (API) from a dosage form, measured b...
Biorelevant dissolution instruments represent an important tool for pharmaceutical research and deve...
Dissolution tests are used for many purposes in the pharmaceutical industry: in the development of n...
Many drugs are administered as crystalline particles compressed into tablets and taken orally. When ...
Dissolution testing with biorelevant media has become widespread in the pharmaceutical industry as a...
The rate and extent of drug dissolution in the gastrointestinal (GI) tract are highly dependent upon...
When dissolution testing is used to forecast the in vivoperformance of a drug, it is critical that t...
In the development of new oral drug compounds, poorly water-soluble compounds are a challenge for th...
Purpose . The dissolution behavior of two commercially availableglibenclamide formulations was teste...
Dissolution research started more than a century ago in the field of physical chemistry and went thr...
Oral drug products must dissolve in the gastrointestinal (GI) tract before being absorbed and reachi...
Over the past decade, formulation predictive dissolution (fPD) testing has gained increasing attenti...
Over the past decade, formulation predictive dissolution (fPD) testing has gained increasing attenti...
One of the challenges of biopharmaceutics research is correlating in vitro drug release information ...
The general aim of this thesis was to evaluate a newly designed and constructed miniaturized rotatin...
AbstractThe release rate of an active pharmaceutical ingredient (API) from a dosage form, measured b...